• Telecure Technologies Inc. (TELE) has appointed Eli Dusenbury to its Board of Directors
  • Dusenbury obtained his Chartered Professional Accountant designation in 2011
  • He has also served as consultant for audit and public practice firms in both Canada and the United States
  • Telecure informs the public that Kashif Akram is no longer Chief Technology Officer of Telecure
  • Telecure is a U.S. focused health IT company that specializes in using technology to make healthcare more accessible and efficient
  • Telecure Technologies Inc. (TELE) is sitting at C$0.30 at 9:54 am EST

Telecure Technologies (TELE) has appointed Eli Dusenbury to its Board of Directors, effective immediately.

Dusenbury is also the company’s Chief Financial Officer.

Josh Rosenberg, Chairman of the Board of Directors remarked,

“Dusenbury has been instrumental to Telecure’s success. As Telecure grows I believe Eli will continue to be an invaluable asset with his extensive experience in financial reporting and acquisitions.”

“I look forward to working with Mr. Dusenbury as a Board member as we continue to build a strong foundation for the future of Telecure,” added Rosenberg.

Dusenbury, CPA, CA has experience in public accounting, providing services to both public and private sector clients reporting in Canada and in the United States across a broad range of industries including healthcare, technology, agriculture, engineering, mining & exploration, manufacturing and financing.

Dusenbury obtained his Chartered Professional Accountant designation in 2011.

He has also served as a consultant for audit and public practice firms in both Canada and the United States and has held Directorships and Chief Financial Officer positions for multiple international public and private entities.

Telecure has also announced that Kashif Akram is no longer the Chief Technology Officer.

Telecure is a U.S.-focused health IT company that specializes in using technology to make healthcare more accessible and efficient. Telecure offers customized solutions for telemedicine needs.

Through an acquisition strategy and unique customization capabilities, Telecure is focused on advancing its patient and user base.

Telecure Technologies Inc. (TELE) is sitting at C$0.30 at 9:54 am EST.

More From The Market Online

Microsoft stock rallies after Q3 results beat expectations

Microsoft (NASDAQ:MSFT) shares rose nearly 3 per cent early Friday after its fiscal Q3 results beat Wall Street's expectations.
Fobi AI Canadian equestrian Kassidy Keith

Fobi AI to sponsor Canadian equestrian Kassidy Keith

Fobi AI (TSXV:FOBI), an AI and data intelligence stock, inks a two-year sponsorship agreement with Canadian equestrian Kassidy Keith.

Samsung invests in NFT Technologies portfolio company

Samsung takes a stake in Metablox, a decentralized physical infrastructure network backed by NFT Technologies (NEO:NFT).